Can ChatGPT spot cancer cells as well as a pathologist?
NCT ID NCT07228689
First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 3 times
Summary
This study is testing whether an AI tool (ChatGPT) can accurately identify abnormal cells in biopsy samples taken during an endoscopic ultrasound. About 136 adults with solid masses in the digestive tract will have their biopsy images reviewed by both the AI and expert pathologists. The goal is to see if AI can provide a fast, reliable on-the-spot diagnosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ChatGPT artificial intelligence platform
- What this could lead to
- If successful, this could show that AI can help doctors quickly and accurately analyze biopsy samples during procedures, potentially speeding up diagnosis.
- What could go wrong
- This is a relatively small, single-center study. AI may not be as accurate as human experts, and results may not apply to other settings or types of samples.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Orlando Health Digestive Health Institute
Orlando, Florida, 32806, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.